Sonidegib is a medication that belongs to a class of drugs known as hedgehog pathway inhibitors. It is primarily used in the treatment of a type of skin cancer called basal cell carcinoma that has spread to other parts of the body or cannot be treated with surgery or radiation therapy.

This medication works by blocking a specific protein in the hedgehog signaling pathway, which plays a key role in the growth and development of cancer cells. By inhibiting this pathway, sonidegib helps to slow down or stop the growth of cancer cells, ultimately leading to a reduction in tumor size and progression of the disease.

It is important to note that sonidegib is not a cure for basal cell carcinoma, but it can help to control the disease and improve quality of life for patients. Like all medications, sonidegib may cause side effects, including muscle spasms, hair loss, fatigue, and changes in taste. It is important to discuss any concerns or side effects with your healthcare provider.

As a medical professional, I recommend that patients taking sonidegib follow their healthcare provider’s instructions carefully and attend regular follow-up appointments to monitor their progress and any potential side effects. It is also important to inform your healthcare provider of any other medications or supplements you are taking, as they may interact with sonidegib.

Overall, sonidegib is a valuable treatment option for patients with advanced basal cell carcinoma, and when used as directed, it can help to manage the disease and improve quality of life.